This trial is evaluating whether Conversation Cards for Adolescents and Goal-Setting will improve 1 primary outcome and 14 secondary outcomes in patients with Obesity, Adolescent. Measurement will happen over the course of Baseline.
This trial requires 50 total participants across 2 different treatment groups
This trial involves 2 different treatments. Conversation Cards For Adolescents And Goal-Setting is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
There is great potential that we can learn about obesity prevention and treatment strategies from this study. Recent findings could be used by public health and medical professionals in their efforts to reduce this ever-growing problem in the United States.
While adolescents have been recognized as a subgroup of patients with pediatrician responsibilities for weight, the nature and extent of their responsibilities have been neglected. The obesity rates in adolescents are rising, and adolescents are in a particularly vulnerable population to the risks and consequences of obesity, particularly high-risk obesity. However, there is a poor communication link between adolescent physicians and their patients, and clinicians see little value in discussing obesity with adolescent patients. This lack of knowledge is reflected in practices of pediatricians, nurse practitioners, and physicians. These practitioners see patient education mostly as part of the parent's role and are often not trained to anticipate the adolescent's interest in obesity and seek ways to support adolescent patients' treatment plans.
Obesity, as well as adolescent obesity are major health problems. Symptoms of obesity involve the weight loss symptoms, including the persistent cough, the feeling of hunger, and the feeling of fatigue are clear signs of adolescent obesity.
Obesity has become a epidemic because there is significant heterogeneity in the US population in the proportion of youth and adults that are obese (23.4% of adolescents as of 2017). This epidemiological and genetic diversity between adult obesity and adolescence may alter future health consequences.
Obesity appears to be a treatable condition and can generally be managed if the patient is motivated to follow a treatment path by helping to educate themselves and their caregivers on treatment methods, lifestyle changes, and the risks of obesity, and educating their peers about the risks of obesity.
The origins of obesity are unknown, but there are probably complex environmental factors that modify genes. The reasons for high rates of obesity have yet to be determined; however, it may be linked to a sedentary lifestyle, inadequate intake of physical activity, and stress.
The most widely accepted theory in the Western world and in the global community is that obesity is a consequence of an excessive energy intake, often as a result of low levels of physical activity. However many experts from clinical trials have been doing extensive research together with eligible patients to discover new treatment options where they get to receive them first. Go to the Power (https://www.withpower.com/d/obesity-clinical-trials) website to learn more on how you can find a clinical trial that fits your current condition.
A 10-minute interactive self-management card was effective in decreasing BMI and increasing active transportation in obese adolescents (BMI 31.9-36.9)) from baseline. These small sample size results suggest generalizability to a larger cohort.
Increasing trends were seen in BMI Z scores at age 10, with the highest percentage of overweight and obese children between 10–12 years. Obesity, and particularly overweight/obesity were more prevalent in South than in the North. This is a concern in our society because obesity-associated diseases are becoming more common. As society continues to become more sedentary-oriented, it is more important for obesity prevention efforts to start earlier. We need to educate adolescents about their disease risks and how to prevent and control them (e.g. healthy food choices, exercise, weight) and tailor current obesity prevention interventions to the needs of adolescents.
Given the limited evidence base that already exists, we believe that CCT can be used to support other more recent approaches to support weight loss. We feel that although there is a limited evidence base for support programmes or individualised goal-setting, there would be potential to demonstrate outcomes that are beneficial and cost-efficient.
A [conservation-type strategy to increase cardiorespiratory fitness, nutritional hygiene and limit alcohol consumption did not increase (vs. a control) physical activity, total energy intake and BMI or waist circumference in adolescents who were obese at baseline.
Children aged 5 to 10 years need to be included in any clinical trial of obesity, not only due to the frequency of the disease in this age group. For adolescents, the need for obesity-related clinical studies is even greater. Children aged 10 to 18 years need clinical trials. The choice of study designs, endpoints, and treatment goals should be based on a multidisciplinary evaluation of the risks and benefits.